To investigate effectiveness and safety of belimumab in patients with active systemic lupus erythematosus (SLE) in clinical practice setting.
Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus
ANDREOLI, Laura;Franceschini, Franco;Fredi, Micaela;TINCANI, Angela;
2017-01-01
Abstract
To investigate effectiveness and safety of belimumab in patients with active systemic lupus erythematosus (SLE) in clinical practice setting.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
